7 January 2021
Kite and Oxford Biotherapeutics Establish Cell therapy Research Collaboration in Blood Cancers and Solid Tumours
Santa Monica, Calif.; Oxford, UK; and San Jose, Calif., January 6, 2021 - Kite, a Gilead Company (Nasdaq: GILD), and Oxford BioTherapeutics Ltd. (OBT), a clinical stage oncology company with a pipeline of immuno-oncology (IO) and antibody-drug conjugate (ADC)-based therapies...
5 January 2021
Panthera assists in AstraZeneca’s phase III trial of antibody combination for prevention of Covid-19
Panthera’s clinical trial sites in Preston, North Manchester and North London began dosing volunteers in the Phase III PROVENT trial which will evaluate AstraZeneca’s long-acting antibody combination, AZD7442, for the potential prevention of COVID-19. The...
4 January 2021
British MedTech Rinicare poised to respond to the challenges of the new healthcare environment
Manchester based clinician-led digital health company, Rinicare, has further strengthened its foundations with the appointment of a new Managing Director and the closure of a finance round, which included investment from the Future Fund along with Mercia Asset Management and...
16 December 2020
Pill Connect expands its team with the appointment of Richard Hall as Director of Quality
Pill Connect (formerly known as Elucid Mhealth), a world leader in medicine adherence monitoring and data capture on patient compliance, has expanded its team with the appointment of Richard Hall as Director of Quality. This follows the recent successful funding raise involving...
8 December 2020
Catapult Ventures invests in OVO Biomanufacturing to improve the manufacturing efficiency of viral vaccines and gene therapies
3rd December 2020 - Alderley Park, UK. OVO Biomanufacturing today announced the completion of a new funding round to develop its novel technology platform to improve the manufacturing efficiency for viral vaccines and gene therapies. The funding came from the GM&C Life...
26 November 2020
Exciting new collaboration to develop fully synthetic animal-free scaffolds
Three UK biotechnology companies will combine research expertise to develop fully synthetic animal-free scaffolds overcoming barriers in sustainable and scalable organoid culture in a project funded by Innovate UK. Cardiff-based organoid company, Cellesce, Peptide 3D scaffold...
24 November 2020
Maven Equity Finance NPIF invests alongside Catapult in digital healthcare consent platform Flynotes
A Manchester-based digital healthcare consent platform has secured funding from NPIF - Maven Equity Finance. Flynotes is behind a platform which provides a digital alternative to the paper-based consent and disclosure process. Having developed its product, the company is...
23 November 2020
Maxwellia looking into daily contraceptive Rx-To-OTC switch
As calls for a non-prescription daily contraceptive pill grow in the UK, switch incubator Maxwellia suggests an Rx-to-OTC reclassification of the widely-used progestogen only pill may be one of its first "switch-in-a-box" projects. Responding to a growing demand in the UK for...
18 November 2020
Digi.me partners with Gendius to allow users to connect their health records to its smart diabetes management platform
Digi.me is partnering with British digital health start-up Gendius to allow users to connect their health records to its smart diabetes platform, Intellin®. The deal will mean that digi.me users in the UK will be able to download and consent to share their NHS GP health...
17 November 2020
Cytox publishes research showing genoSCORE-LAB test can predict risk of cognitive decline due to Alzheimer’s without invasive procedures
genoSCORE™-LAB a new genetic test to launch in 2020 enables early assessment of patients with cognitive complaints from a simple saliva or blood sample … 17th November 2020: Oxford and Manchester, UK. Cytox Ltd, which provides non-invasive, risk assessment and patient...